Lonza Bolsters Antibody-Drug
Lonza Bolsters Antibody-Drug Conjugates Portfolio with Synaffix Acquisition
SG Tylor
Lonza, a global manufacturing company acquired Synaffix B.V., a biotechnology company specializing in the advancement of ADCs (antibody-drug conjugates) through ...
